Skip to main content
Industry News
FDA grants breakthrough status to Reflow's PAD treatment system

The FDA has granted Reflow Medical breakthrough device designation for its Temporary Spur Stent system for use in below-the-knee peripheral artery disease treatment. The company eyes continued development of the device in other clinical areas and plans to expand on clinical evidence for the system.

Full Story: